In-vivo and in-vitro techniques used to investigate Alzheimer's disease

References

• Abe H, Nakanishi H. 2003. Novel observation of a circular dichroism band originating from amyloid fibril. Anal Sci. 19:171–173. doi: 10.2116/analsci.19.171
   PubMed Web of Science ®Google Scholar
• Andersson JD, Varnas K, Cselenyi Z, Gulyas B, Wensbo D, Finnema SJ, Swahn BM, Svensson S, Nyberg S, Farde L, et al. 2010. Radiosynthesis of the candidate beta-amyloid radioligand [(11)C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys. Synapse. 64:733–741. doi: 10.1002/syn.20782
   PubMed Web of Science ®Google Scholar
• Balbach JJ, Petkova AT, Oyler NA, Antzutkin ON, Gordon DJ, Meredith SC, Tycko R. 2002. Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys J. 83:1205–1216. doi: 10.1016/S0006-3495(02)75244-2
   PubMed Web of Science ®Google Scholar
• Ban T, Goto Y. 2006. Direct observation of amyloid growth monitored by total internal reflection fluorescence microscopy. Methods Enzymol. 413:91–102. 10.1016/S0076-6879(06)13005-0
   PubMed Web of Science ®Google Scholar
• Baron JC, Chetelat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, Eustache F. 2001. In-vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage. 14:298–309. doi: 10.1006/nimg.2001.0848
   PubMed Web of Science ®Google Scholar
• Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB. 2003a. Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci USA. 100:330–335.
   Google Scholar
• Bitan G, Tarus B, Vollers SS, Lashuel HA, Condron MM, Straub JE, Teplow DB. 2003b. A molecular switch in amyloid assembly: Met35 and amyloid beta-protein oligomerization. J Am Chem Soc. 125:15359–15365. doi: 10.1021/ja0349296
   PubMed Web of Science ®Google Scholar
• Blackley HK, Sanders GH, Davies MC, Roberts CJ, Tendler SJ, Wilkinson MJ. 2000. In-situ atomic force microscopy study of beta-amyloid fibrillization. J Mol Biol. 298:833–840. doi: 10.1006/jmbi.2000.3711
   PubMed Web of Science ®Google Scholar
• Boas JF, Drew SC, Curtain CC. 2008. Applications of electron paramagnetic resonance to studies of neurological disease. Eur Biophys J. 37:281–294. doi: 10.1007/s00249-008-0261-8
   PubMed Web of Science ®Google Scholar
• Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW. 2000. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med. 343:450–456. doi: 10.1056/NEJM200008173430701
   PubMed Web of Science ®Google Scholar
• Bozzao A, Floris R, Baviera ME, Apruzzese A, Simonetti G. 2001. Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. AJNR Am J Neuroradiol. 22:1030–1036.
   PubMed Web of Science ®Google Scholar
• Brigger D, Muckle RJ. 1975. Comparison of Sirius red and Congo red as stains for amyloid in animal tissues. J Histochem Cytochem. 23:84–88. doi: 10.1177/23.1.46874
   PubMed Web of Science ®Google Scholar
• Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W, et al. 1997. The cellular prion protein binds copper in-vivo. Nature. 390:684–687. doi: 10.1038/37733
   PubMed Web of Science ®Google Scholar
• Brunger AT. 1997. X-ray crystallography and NMR reveal complementary views of structure and dynamics. Nat Struct Biol. 4 Suppl:862–865.
   PubMedGoogle Scholar
• Burton EJ, Karas G, Paling SM, Barber R, Williams ED, Ballard CG, McKeith IG, Scheltens P, Barkhof F, O'Brien JT. 2002. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage. 17:618–630. doi: 10.1006/nimg.2002.1197
   PubMed Web of Science ®Google Scholar
• Butterfield DA. 2003. Amyloid beta-peptide [1–42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences. Curr Med Chem. 10:2651–2659. doi: 10.2174/0929867033456422
   PubMed Web of Science ®Google Scholar
• Chen JG, Charles HC, Barboriak DP, Doraiswamy PM. 2000. Magnetic resonance spectroscopy in Alzheimer's disease: focus on N-acetylaspartate. Acta Neurol Scand Suppl. 176:20–26. doi:10.1034/j.1600-0404.2000.00303.x
   PubMedGoogle Scholar
• Chen M, Margittai M, Chen J, Langen R. 2007. Investigation of alpha-synuclein fibril structure by site-directed spin labeling. J Biol Chem. 282:24970–24979. doi: 10.1074/jbc.M700368200
   PubMed Web of Science ®Google Scholar
• Cheng Y, Ono M, Kimura H, Ueda M, Saji H. 2012. Technetium-99m labeled pyridyl benzofuran derivatives as single photon emission computed tomography imaging probes for beta-amyloid plaques in Alzheimer's brains. J Med Chem. 55:2279–2286. doi: 10.1021/jm201513c
   PubMed Web of Science ®Google Scholar
• Chitcholtan K, Hampton MB, Keenan JI. 2008. Outer membrane vesicles enhance the carcinogenic potential of Helicobacter pylori. Carcinogenesis. 29:2400–2405. doi: 10.1093/carcin/bgn218
   PubMed Web of Science ®Google Scholar
• Choi JK, Dedeoglu A, Jenkins BG. 2007. Application of MRS to mouse models of neurodegenerative illness. NMR Biomed. 20:216–237. doi: 10.1002/nbm.1145
   PubMed Web of Science ®Google Scholar
• Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, Benedum TE, Kilbourn MR, Skovronsky D, Kung HF. 2009. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. J Nucl Med. 50:1887–1894. doi: 10.2967/jnumed.109.065284
   PubMed Web of Science ®Google Scholar
• Coles M, Bicknell W, Watson AA, Fairlie DP, Craik DJ. 1998. Solution structure of amyloid beta-peptide(1–40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry. 37:11064–11077. doi: 10.1021/bi972979f
   PubMed Web of Science ®Google Scholar
• Colinge J, Chiappe D, Lagache S, Moniatte M, Bougueleret L. 2005. Differential proteomics via probabilistic peptide identification scores. Anal Chem. 77:596–606. doi: 10.1021/ac0488513
   PubMed Web of Science ®Google Scholar
• Courtney SM, Ungerleider LG, Keil K, Haxby JV. 1997. Transient and sustained activity in a distributed neural system for human working memory. Nature. 386:608–611. doi: 10.1038/386608a0
   PubMed Web of Science ®Google Scholar
• Cselenyi Z, Jonhagen ME, Forsberg A, Halldin C, Julin P, Schou M, Johnstrom P, Varnas K, Svensson S, Farde L. 2012. Clinical validation of 18F-AZD4694, an amyloid-beta-specific PET radioligand. J Nucl Med. 53:415–424. doi: 10.2967/jnumed.111.094029
   PubMed Web of Science ®Google Scholar
• Csernansky JG, Wang L, Swank J, Miller JP, Gado M, McKeel D, Miller MI, Morris JC. 2005. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage. 25:783–792. doi: 10.1016/j.neuroimage.2004.12.036
   PubMed Web of Science ®Google Scholar
• de Graaf RA, Mason GF, Patel AB, Rothman DL, Behar KL. 2004. Regional glucose metabolism and glutamatergic neurotransmission in rat brain in-vivo. Proc Natl Acad Sci USA. 101:12700–12705.
   Google Scholar
• DeCarli C, Murphy DG, McIntosh AR, Teichberg D, Schapiro MB, Horwitz B. 1995. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res. 57:119–130. doi: 10.1016/0165-1781(95)02651-C
   PubMed Web of Science ®Google Scholar
• del Pino P, Weiss A, Bertsch U, Renner C, Mentler M, Grantner K, Fiorino F, Meyer-Klaucke W, Moroder L, Kretzschmar HA, et al. 2007. The configuration of the Cu2+ binding region in full-length human prion protein. Eur Biophys J. 36:239–252. doi: 10.1007/s00249-006-0124-0
   PubMed Web of Science ®Google Scholar
• Dobson CM. 2004. Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol. 15:3–16. doi: 10.1016/j.semcdb.2003.12.008
   PubMed Web of Science ®Google Scholar
• Duchesne S, Caroli A, Geroldi C, Barillot C, Frisoni GB, Collins DL. 2008. MRI-based automated computer classification of probable AD versus normal controls. IEEE Trans Med Imaging. 27:509–520. doi: 10.1109/TMI.2007.908685
   PubMed Web of Science ®Google Scholar
• Dyson HJ, Wright PE. 2004. Unfolded proteins and protein folding studied by NMR. Chem Rev. 104:3607–3622. doi: 10.1021/cr030403s
   PubMed Web of Science ®Google Scholar
• Elghetany MT, Saleem A, Barr K. 1989. The congo red stain revisited. Ann Clin Lab Sci. 19:190–195.
   PubMed Web of Science ®Google Scholar
• Elghetany MT, Saleem A. 1988. Methods for staining amyloid in tissues: a review. Stain Technol. 63:201–212.
   PubMed Web of Science ®Google Scholar
• Esposito G, Corazza A, Viglino P, Verdone G, Pettirossi F, Fogolari F, Makek A, Giorgetti S, Mangione P, Stoppini M, et al. 2005. Solution structure of beta(2)-microglobulin and insights into fibrillogenesis. Biochim Biophys Acta. 1753:76–84. doi: 10.1016/j.bbapap.2005.07.003
   PubMed Web of Science ®Google Scholar
• Fezoui Y, Teplow DB. 2002. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. J Biol Chem. 277:36948–36954. doi: 10.1074/jbc.M204168200
   PubMed Web of Science ®Google Scholar
• Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, Langstrom B, Nordberg A. 2008. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging. 29:1456–1465. doi: 10.1016/j.neurobiolaging.2007.03.029
   PubMed Web of Science ®Google Scholar
• Forsberg A, Jureus A, Cselenyi Z, Eriksdotter M, Freund-Levi Y, Jeppsson F, Swahn BM, Sandell J, Julin P, Schou M, et al. 2013. Low background and high contrast PET imaging of amyloid-beta with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients. Eur J Nucl Med Mol Imaging. 40:580–593. doi: 10.1007/s00259-012-2322-6
   PubMed Web of Science ®Google Scholar
• Gaeta A, Hider RC. 2005. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol. 146:1041–1059. doi: 10.1038/sj.bjp.0706416
   PubMed Web of Science ®Google Scholar
• Goldsbury C, Frey P, Olivieri V, Aebi U, Muller SA. 2005. Multiple assembly pathways underlie amyloid-beta fibril polymorphisms. J Mol Biol. 352:282–298. doi: 10.1016/j.jmb.2005.07.029
   PubMed Web of Science ®Google Scholar
• Goldsbury C, Green J. 2005. Time-lapse atomic force microscopy in the characterization of amyloid-like fibril assembly and oligomeric intermediates. Methods Mol Biol. 299:103–128.
   PubMedGoogle Scholar
• Goldsbury CS, Wirtz S, Muller SA, Sunderji S, Wicki P, Aebi U, Frey P. 2000. Studies on the in-vitro assembly of a beta 1–40: implications for the search for a beta fibril formation inhibitors. J Struct Biol. 130:217–231. doi: 10.1006/jsbi.2000.4259
   PubMed Web of Science ®Google Scholar
• Gonzalez RG, Fischman AJ, Guimaraes AR, Carr CA, Stern CE, Halpern EF, Growdon JH, Rosen BR. 1995. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. AJNR Am J Neuroradiol. 16:1763–1770.
   PubMed Web of Science ®Google Scholar
• Govindaraju V, Young K, Maudsley AA. 2000. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 13:129–153. doi: 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V
   PubMed Web of Science ®Google Scholar
• Greenfield NJ. 2006. Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc. 1:2876–2890. doi:10.1038/nprot.2006.202
   PubMed Web of Science ®Google Scholar
• Griffith HR, den Hollander JA, Okonkwo OC, O'Brien T, Watts RL, Marson DC. 2008. Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia. Alzheimers Dement. 4:421–427. doi: 10.1016/j.jalz.2008.04.008
   PubMed Web of Science ®Google Scholar
• Hansma PK, Elings VB, Marti O, Bracker CE. 1988. Scanning tunneling microscopy and atomic force microscopy: application to biology and technology. Science. 242:209–216. doi: 10.1126/science.3051380
   PubMed Web of Science ®Google Scholar
• Hanyu H, Sakurai H, Iwamoto T, Takasaki M, Shindo H, Abe K. 1998. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. J Neurol Sci. 156:195–200. doi: 10.1016/S0022-510X(98)00043-4
   PubMed Web of Science ®Google Scholar
• Hanyu H, Shindo H, Kakizaki D, Abe K, Iwamoto T, Takasaki M. 1997. Increased water diffusion in cerebral white matter in Alzheimer's disease. Gerontology. 43:343–351. doi:10.1159/000213874
   PubMed Web of Science ®Google Scholar
• Harper JD, Lieber CM, Lansbury PT, Jr. 1997. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem Biol. 4:951–959. doi: 10.1016/S1074-5521(97)90303-3
   PubMed Web of Science ®Google Scholar
• Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF. 1996. Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease. Am J Psychiatry. 153:721–724. doi: 10.1176/ajp.153.5.721
   PubMed Web of Science ®Google Scholar
• Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF. 1998. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. AJNR Am J Neuroradiol. 19:1727–1732.
   PubMed Web of Science ®Google Scholar
• Harris GJ, Links JM, Pearlson GD, Camargo EE. 1991. Cortical circumferential profile of SPECT cerebral perfusion in Alzheimer's disease. Psychiatry Res. 40:167–180. doi: 10.1016/0925-4927(91)90008-E
   PubMed Web of Science ®Google Scholar
• Heise H. 2008. Solid-state NMR spectroscopy of amyloid proteins. Chembiochem: A Eur J Chemical Biol. 9:179–189. doi: 10.1002/cbic.200700630
   PubMed Web of Science ®Google Scholar
• Herholz K. 2003. PET studies in dementia. Ann Nucl Med. 17:79–89. doi: 10.1007/BF02988444
   PubMed Web of Science ®Google Scholar
• Hetherington H, Kuzniecky R, Pan J, Mason G, Morawetz R, Harris C, Faught E, Vaughan T, Pohost G. 1995. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol. 38:396–404. doi: 10.1002/ana.410380309
   PubMed Web of Science ®Google Scholar
• Hou L, Shao H, Zhang Y, Li H, Menon NK, Neuhaus EB, Brewer JM, Byeon IJ, Ray DG, Vitek MP, et al. 2004. Solution NMR studies of the A beta(1–40) and A beta(1–42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J Am Chem Soc. 126:1992–2005. doi: 10.1021/ja036813f
   PubMed Web of Science ®Google Scholar
• Huang W, Alexander GE, Chang L, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB. 2001. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology. 57:626–632. doi: 10.1212/WNL.57.4.626
   PubMed Web of Science ®Google Scholar
• Ishii K, Kawachi T, Sasaki H, Kono AK, Fukuda T, Kojima Y, Mori E. 2005. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am J Neuroradiol. 26:333–340.
   PubMed Web of Science ®Google Scholar
• Jack CR, Jr., Petersen RC, O'Brien PC, Tangalos EG. 1992. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology. 42:183–188. doi: 10.1212/WNL.42.1.183
   PubMed Web of Science ®Google Scholar
• Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA, et al. 2010. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement. 6:221–229. doi: 10.1016/j.jalz.2010.03.003
   PubMed Web of Science ®Google Scholar
• Jansen D, Zerbi V, Janssen CI, Dederen PJ, Mutsaers MP, Hafkemeijer A, Janssen AL, Nobelen CL, Veltien A, Asten JJ, et al. 2013. A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AbetaPPswe-PS1dE9 mice. PloS One. 8:e63643. doi:10.1371/journal.pone.0063643
   PubMedGoogle Scholar
• Jayasinghe SA, Langen R. 2004. Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling. J Chem. 279:48420–48425.
   Web of Science ®Google Scholar
• Jessen F, Gur O, Block W, Ende G, Frolich L, Hammen T, Wiltfang J, Kucinski T, Jahn H, Heun R, et al. 2009. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology. 72:1735–1740. doi: 10.1212/WNL.0b013e3181a60a20
   PubMed Web of Science ®Google Scholar
• Jin LW, Claborn KA, Kurimoto M, Geday MA, Maezawa I, Sohraby F, Estrada M, Kaminksy W, Kahr B. 2003. Imaging linear birefringence and dichroism in cerebral amyloid pathologies. Proc Natl Acad Sci USA. 100:15294–15298.
   Google Scholar
• Johnson AE, Jeppsson F, Sandell J, Wensbo D, Neelissen JA, Jureus A, Strom P, Norman H, Farde L, Svensson SP. 2009. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits. J Neurochem. 108:1177–1186. doi: 10.1111/j.1471-4159.2008.05861.x
   PubMed Web of Science ®Google Scholar
• Johnson SC, Saykin AJ, Baxter LC, Flashman LA, Santulli RB, McAllister TW, Mamourian AC. 2000. The relationship between fMRI activation and cerebral atrophy: comparison of normal aging and alzheimer disease. Neuroimage. 11:179–187. doi: 10.1006/nimg.1999.0530
   PubMed Web of Science ®Google Scholar
• Jolles J, Bothmer J, Markerink M, Ravid R. 1992. Phosphatidylinositol kinase is reduced in Alzheimer's disease. J Neurochem. 58:2326–2329. doi: 10.1111/j.1471-4159.1992.tb10981.x
   PubMed Web of Science ®Google Scholar
• Jureus A, Swahn BM, Sandell J, Jeppsson F, Johnson AE, Johnstrom P, Neelissen JA, Sunnemark D, Farde L, Svensson SP. 2010. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand. J Neurochem. 114:784–794. doi: 10.1111/j.1471-4159.2010.06812.x
   PubMed Web of Science ®Google Scholar
• Kamihira M, Naito A, Tuzi S, Nosaka AY, Saito H. 2000. Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR. Protein Sci. 9:867–877. doi: 10.1110/ps.9.5.867
   PubMed Web of Science ®Google Scholar
• Kanetaka H, Matsuda H, Asada T, Ohnishi T, Yamashita F, Imabayashi E, Tanaka F, Nakano S, Takasaki M. 2004. Effects of partial volume correction on discrimination between very early Alzheimer's dementia and controls using brain perfusion SPECT. Eur J Nucl Med Mol Imaging. 31:975–980. doi: 10.1007/s00259-004-1491-3
   PubMed Web of Science ®Google Scholar
• Kantarci K, Jack CR, Jr. 2003. Neuroimaging in Alzheimer disease: an evidence-based review. Neuroimaging Clin N Am. 13:197–209. doi: 10.1016/S1052-5149(03)00025-X
   PubMed Web of Science ®Google Scholar
• Kantarci K, Jack CR, Jr., Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, et al. 2001. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology. 219:101–107. doi: 10.1148/radiology.219.1.r01ap14101
   PubMed Web of Science ®Google Scholar
• Kantarci K, Knopman DS, Dickson DW, Parisi JE, Whitwell JL, Weigand SD, Josephs KA, Boeve BF, Petersen RC, Jack CR, Jr. 2008. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology. 248:210–220. doi: 10.1148/radiol.2481071590
   PubMed Web of Science ®Google Scholar
• Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, et al. 2004. 1H MR spectroscopy in common dementias. Neurology. 63:1393–1398. doi: 10.1212/01.WNL.0000141849.21256.AC
   PubMed Web of Science ®Google Scholar
• Kantarci K, Weigand SD, Petersen RC, Boeve BF, Knopman DS, Gunter J, Reyes D, Shiung M, O'Brien PC, Smith GE, et al. 2007. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 28:1330–1339. doi: 10.1016/j.neurobiolaging.2006.06.018
   PubMed Web of Science ®Google Scholar
• Kantarci K, Weigand SD, Przybelski SA, Shiung MM, Whitwell JL, Negash S, Knopman DS, Boeve BF, O'Brien PC, Petersen RC, et al. 2009. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology. 72:1519–1525. doi: 10.1212/WNL.0b013e3181a2e864
   PubMed Web of Science ®Google Scholar
• Kantarci K. 2007. 1H magnetic resonance spectroscopy in dementia. Br J Radiol. 80 Spec No 2:S146–152. doi: 10.1259/bjr/60346217
   PubMedGoogle Scholar
• Kawachi T, Ishii K, Sakamoto S, Sasaki M, Mori T, Yamashita F, Matsuda H, Mori E. 2006. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease. Eur J Nucl Med Mol Imaging. 33:801–809. doi: 10.1007/s00259-005-0050-x
   PubMed Web of Science ®Google Scholar
• Kemppainen NM, Aalto S, Wilson IA, Nagren K, Helin S, Bruck A, Oikonen V, Kailajarvi M, Scheinin M, Viitanen M, et al. 2006. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology. 67:1575–1580. doi: 10.1212/01.wnl.0000240117.55680.0a
   PubMed Web of Science ®Google Scholar
• Kheterpal I, Lashuel HA, Hartley DM, Walz T, Lansbury PTJr., Wetzel R. 2003. Abeta protofibrils possess a stable core structure resistant to hydrogen exchange. Biochemistry. 42:14092–14098. doi: 10.1021/bi0357816
   PubMed Web of Science ®Google Scholar
• Khurana R, Coleman C, Ionescu-Zanetti C, Carter SA, Krishna V, Grover RK, Roy R, Singh S. 2005. Mechanism of thioflavin T binding to amyloid fibrils. J Struct Biol. 151:229–238. doi: 10.1016/j.jsb.2005.06.006
   PubMed Web of Science ®Google Scholar
• Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS. 2002. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 58:1188–1196. doi: 10.1212/WNL.58.8.1188
   PubMed Web of Science ®Google Scholar
• Kim J, Lee M. 2004. Observation of multi-step conformation switching in beta-amyloid peptide aggregation by fluorescence resonance energy transfer. Biochem Biophys Res Commun. 316:393–397. doi: 10.1016/j.bbrc.2004.02.059
   PubMed Web of Science ®Google Scholar
• Kirshenbaum K, Daggett V. 1995. Sequence effects on the conformational properties of the amyloid beta (1–28) peptide: testing a proposed mechanism for the alpha→beta transition. Biochemistry. 34:7640–7647. doi: 10.1021/bi00023a010
   PubMed Web of Science ®Google Scholar
• Kloppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR, Jr., Ashburner J, Frackowiak RS. 2008. Automatic classification of MR scans in Alzheimer's disease. Brain: A J Neurol. 131:681–689. doi: 10.1093/brain/awm319
   PubMed Web of Science ®Google Scholar
• Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, et al. 2004. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 55:306–319. doi: 10.1002/ana.20009
   PubMed Web of Science ®Google Scholar
• Klunk WE, Pettegrew JW, Abraham DJ. 1989. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J Histochem Cytochem. 37:1273–1281. doi: 10.1177/37.8.2666510
   PubMed Web of Science ®Google Scholar
• Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Mathis CA. 2001. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 69:1471–1484. doi: 10.1016/S0024-3205(01)01232-2
   PubMed Web of Science ®Google Scholar
• Klunk WE. 1998. Biological markers of Alzheimer's disease. Neurobiol Aging. 19:145–147. doi: 10.1016/S0197-4580(98)00013-X
   PubMed Web of Science ®Google Scholar
• Klunk WE. 2011. Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia. Neurobiol Aging. 32 Suppl 1:S20–36. doi: 10.1016/j.neurobiolaging.2011.09.006
   PubMedGoogle Scholar
• Koole M, Lewis DM, Buckley C, Nelissen N, Vandenbulcke M, Brooks DJ, Vandenberghe R, Van Laere K. 2009. Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in-vivo brain amyloid imaging. J Nucl Med. 50:818–822. doi: 10.2967/jnumed.108.060756
   PubMed Web of Science ®Google Scholar
• Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, Itoh M, Iwata R, Yanai K, Arai H. 2007. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in-vivo detection of dense amyloid plaques in Alzheimer's disease patients. J Nucl Med. 48:553–561. doi: 10.2967/jnumed.106.037556
   PubMed Web of Science ®Google Scholar
• Kung HF, Choi SR, Qu W, Zhang W, Skovronsky D. 2010. 18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective. J Med Chem. 53:933–941. doi: 10.1021/jm901039z
   PubMed Web of Science ®Google Scholar
• Kung MP, Hou C, Zhuang ZP, Cross AJ, Maier DL, Kung HF. 2004. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice. Eur J Nucl Med Mol Imaging. 31:1136–1145. doi: 10.1007/s00259-004-1487-z
   PubMed Web of Science ®Google Scholar
• Kung MP, Hou C, Zhuang ZP, Zhang B, Skovronsky D, Trojanowski JQ, Lee VM, Kung HF. 2002. IMPY: an improved thioflavin-T derivative for in-vivo labeling of beta-amyloid plaques. Brain Res. 956:202–210. doi: 10.1016/S0006-8993(02)03436-4
   PubMed Web of Science ®Google Scholar
• Lansbury PTJr., Costa PR, Griffiths JM, Simon EJ, Auger M, Halverson KJ, Kocisko DA, Hendsch ZS, Ashburn TT, Spencer RG, et al. 1995. Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat Struct Biol. 2:990–998. doi: 10.1038/nsb1195-990
   PubMedGoogle Scholar
• Lashuel HA, Wall JS. 2005. Molecular electron microscopy approaches to elucidating the mechanisms of protein fibrillogenesis. Methods Mol Biol. 299:81–101.
   PubMedGoogle Scholar
• Lee JC, Langen R, Hummel PA, Gray HB, Winkler JR. 2004. Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease. Proc Natl Acad Sci USA. 101:16466–16471.
   Google Scholar
• Lee JH, Bhak G, Lee SG, Paik SR. 2008. Instantaneous amyloid fibril formation of alpha-synuclein from the oligomeric granular structures in the presence of hexane. Biophys J. 95:L16–18. doi: 10.1529/biophysj.108.135186
   PubMedGoogle Scholar
• LeVine H, III. 1999. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309:274–284. doi:10.1016/S0076-6879(99)09020-5
   PubMed Web of Science ®Google Scholar
• Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, Kemppainen N, Nagren K, Kim BC, Tsui W, et al. 2008. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging. 35:2169–2181. doi: 10.1007/s00259-008-0833-y
   PubMed Web of Science ®Google Scholar
• Lin KJ, Hsu WC, Hsiao IT, Wey SP, Jin LW, Skovronsky D, Wai YY, Chang HP, Lo CW, Yao CH, et al. 2010. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent – a pilot study. Nucl Med Biol. 37:497–508. doi: 10.1016/j.nucmedbio.2010.02.003
   PubMed Web of Science ®Google Scholar
• Losic D, Martin LL, Mechler A, Aguilar MI, Small DH. 2006. High resolution scanning tunnelling microscopy of the beta-amyloid protein (Abeta1–40) of Alzheimer's disease suggests a novel mechanism of oligomer assembly. J Struct Biol. 155:104–110. doi: 10.1016/j.jsb.2006.02.013
   PubMed Web of Science ®Google Scholar
• Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H, Schubert D, Riek R. 2005. 3D structure of Alzheimer's amyloid-beta(1–42) fibrils. Proc Natl Acad Sci USA. 102:17342–17347.
   Google Scholar
• Maas LC, Harris GJ, Satlin A, English CD, Lewis RF, Renshaw PF. 1997. Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in Alzheimer's disease: a principal components analysis. J Magn Reson Imaging. 7:215–219. doi: 10.1002/jmri.1880070133
   PubMed Web of Science ®Google Scholar
• Makin OS, Serpell LC. 2005. Structures for amyloid fibrils. FEBS J. 272:5950–5961. doi: 10.1111/j.1742-4658.2005.05025.x
   PubMed Web of Science ®Google Scholar
• Mandal PK, Pettegrew JW, McKeag DW, Mandal R. 2006. Alzheimer's disease: halothane induces Abeta peptide to oligomeric form–solution NMR studies. Neurochem Res. 31:883–890. doi: 10.1007/s11064-006-9092-0
   PubMed Web of Science ®Google Scholar
• Mathis CA, Wang Y, Klunk WE. 2004. Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain. Curr Pharm Des. 10:1469–1492. 10.2174/1381612043384772 doi: 10.2174/1381612043384772
   PubMed Web of Science ®Google Scholar
• Meguro K, LeMestric C, Landeau B, Desgranges B, Eustache F, Baron JC. 2001. Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study. J Neurol Neurosurg Psychiatry. 71:315–321. doi: 10.1136/jnnp.71.3.315
   PubMed Web of Science ®Google Scholar
• Melhem ER, Mori S, Mukundan G, Kraut MA, Pomper MG, van Zijl PC. 2002. Diffusion tensor MR imaging of the brain and white matter tractography. AJR Am J Roentgenol. 178:3–16. doi: 10.2214/ajr.178.1.1780003
   PubMed Web of Science ®Google Scholar
• Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. 1993. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology. 187:433–437. doi: 10.1148/radiology.187.2.8475286
   PubMed Web of Science ®Google Scholar
• Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC. 2006. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology. 67:446–452. doi: 10.1212/01.wnl.0000228230.26044.a4
   PubMed Web of Science ®Google Scholar
• Misra C, Fan Y, Davatzikos C. 2009. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage. 44:1415–1422. doi: 10.1016/j.neuroimage.2008.10.031
   PubMed Web of Science ®Google Scholar
• Mlynarik V, Cacquevel M, Sun-Reimer L, Janssens S, Cudalbu C, Lei H, Schneider BL, Aebischer P, Gruetter R. 2012. Proton and phosphorus magnetic resonance spectroscopy of a mouse model of Alzheimer's disease. J Alzheimers Dis. 31 Suppl 3:S87–99.
   PubMedGoogle Scholar
• Moats RA, Shonk T. 1995. Evaluation of automated MR spectroscopy: application in Alzheimer disease. AJNR Am J Neuroradiol. 16:1779–1782.
   PubMed Web of Science ®Google Scholar
• Modler AJ, Gast K, Lutsch G, Damaschun G. 2003. Assembly of amyloid protofibrils via critical oligomers – a novel pathway of amyloid formation. J Mol Biol. 325:135–148. doi: 10.1016/S0022-2836(02)01175-0
   PubMed Web of Science ®Google Scholar
• Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. 2007. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 81:89–131. doi: 10.1016/j.pneurobio.2006.12.003
   PubMed Web of Science ®Google Scholar
• Morante S, Gonzalez-Iglesias R, Potrich C, Meneghini C, Meyer-Klaucke W, Menestrina G, Gasset M. 2004. Inter- and intra-octarepeat Cu(II) site geometries in the prion protein: implications in Cu(II) binding cooperativity and Cu(II)-mediated assemblies. J Biol Chem. 279:11753–11759. doi: 10.1074/jbc.M312860200
   PubMed Web of Science ®Google Scholar
• Mosconi L. 2005. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging. 32:486–510. doi: 10.1007/s00259-005-1762-7
   PubMed Web of Science ®Google Scholar
• Munishkina LA, Fink AL. 2007. Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins. Biochim Biophys Acta. 1768:1862–1885. doi: 10.1016/j.bbamem.2007.03.015
   PubMed Web of Science ®Google Scholar
• Murakami K, Hara H, Masuda Y, Ohigashi H, Irie K. 2007. Distance measurement between Tyr10 and Met35 in amyloid beta by site-directed spin-labeling ESR spectroscopy: implications for the stronger neurotoxicity of Abeta42 than Abeta40. Chembiochem: A European J Chem Biol. 8:2308–2314. doi: 10.1002/cbic.200700240
   PubMed Web of Science ®Google Scholar
• Murakami K, Irie K, Ohigashi H, Hara H, Nagao M, Shimizu T, Shirasawa T. 2005. Formation and stabilization model of the 42-mer Abeta radical: implications for the long-lasting oxidative stress in Alzheimer's disease. J Am Chem Soc. 127:15168–15174. doi: 10.1021/ja054041c
   PubMed Web of Science ®Google Scholar
• Naito A, Kamihira M, Inoue R, Saito H. 2004. Structural diversity of amyloid fibril formed in human calcitonin as revealed by site-directed 13C solid-state NMR spectroscopy. Magn Reson Chem: MRC. 42:247–257. doi: 10.1002/mrc.1323
   PubMed Web of Science ®Google Scholar
• Naito A, Kawamura I. 2007. Solid-state NMR as a method to reveal structure and membrane-interaction of amyloidogenic proteins and peptides. Biochim Biophys Acta. 1768:1900–1912. doi: 10.1016/j.bbamem.2007.03.025
   PubMed Web of Science ®Google Scholar
• Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D. 2005. Structure of the cross-beta spine of amyloid-like fibrils. Nature. 435:773–778. doi: 10.1038/nature03680
   PubMed Web of Science ®Google Scholar
• Newberg AB, Wintering NA, Plossl K, Hochold J, Stabin MG, Watson M, Skovronsky D, Clark CM, Kung MP, Kung HF. 2006. Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. J Nucl Med. 47:748–754.
   PubMed Web of Science ®Google Scholar
• Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, Ackermann U, Saunder T, Tochon-Danguy H, Jones G, et al. 2007. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease. J Nucl Med. 48:547–552. doi: 10.2967/jnumed.106.037762
   PubMed Web of Science ®Google Scholar
• Nichols MR, Moss MA, Reed DK, Lin WL, Mukhopadhyay R, Hoh JH, Rosenberry TL. 2002. Growth of beta-amyloid(1–40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry. 41:6115–6127. doi: 10.1021/bi015985r
   PubMed Web of Science ®Google Scholar
• Niskanen E, Kononen M, Maatta S, Hallikainen M, Kivipelto M, Casarotto S, Massimini M, Vanninen R, Mervaala E, Karhu J, et al. 2011. New insights into Alzheimer's disease progression: a combined TMS and structural MRI study. PloS One. 6:e26113. doi:10.1371/journal.pone.0026113
   PubMedGoogle Scholar
• Nyberg S, Jonhagen ME, Cselenyi Z, Halldin C, Julin P, Olsson H, Freund-Levi Y, Andersson J, Varnas K, Svensson S, et al. 2009. Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184. Eur J Nucl Med Mol Imaging. 36:1859–1863. doi: 10.1007/s00259-009-1182-1
   PubMed Web of Science ®Google Scholar
• Okamura N, Arai H, Higuchi M, Tashiro M, Matsui T, Hu XS, Takeda A, Itoh M, Sasaki H. 2001. [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 25:447–456. doi: 10.1016/S0278-5846(01)80005-1
   PubMed Web of Science ®Google Scholar
• Ono M, Cheng Y, Kimura H, Cui M, Kagawa S, Nishii R, Saji H. 2011. Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of beta-amyloid plaques in Alzheimer's brains. J Med Chem. 54:2971–2979. doi: 10.1021/jm200057u
   PubMed Web of Science ®Google Scholar
• Ono M, Cheng Y, Kimura H, Watanabe H, Matsumura K, Yoshimura M, Iikuni S, Okamoto Y, Ihara M, Takahashi R, et al. 2013. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of beta-amyloid plaques in Alzheimer's disease. PloS One. 8:e74104. doi:10.1371/journal.pone.0074104
   PubMedGoogle Scholar
• Pastor MT, Kummerer N, Schubert V, Esteras-Chopo A, Dotti CG, Lopez de la Paz M, Serrano L. 2008. Amyloid toxicity is independent of polypeptide sequence, length and chirality. J Mol Biol. 375:695–707. doi: 10.1016/j.jmb.2007.08.012
   PubMed Web of Science ®Google Scholar
• Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissinen A, Helkala EL, et al. 2004. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging. 25:303–310. doi: 10.1016/S0197-4580(03)00084-8
   PubMed Web of Science ®Google Scholar
• Perdomo AB, Ciccosanti F, Iacono OL, Angeletti C, Corazzari M, Daniele N, Testa A, Pisa R, Ippolito G, Antonucci G, et al. 2012. Liver protein profiling in chronic hepatitis C: identification of potential predictive markers for interferon therapy outcome. J Proteome Res. 11:717–727. doi: 10.1021/pr2006445
   PubMed Web of Science ®Google Scholar
• Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R. 2005. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science. 307:262–265. doi: 10.1126/science.1105850
   PubMed Web of Science ®Google Scholar
• Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO. 1999. In-vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magnetic Reson Med. 41:276–284. doi: 10.1002/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8
   PubMed Web of Science ®Google Scholar
• Pickut BA, Dierckx RA, Dobbeleir A, Audenaert K, Van Laere K, Vervaet A, De Deyn PP. 1999. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type. Psychiatry Res. 90:103–112. doi: 10.1016/S0925-4927(99)00004-9
   PubMed Web of Science ®Google Scholar
• Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. 1996. Diffusion tensor MR imaging of the human brain. Radiology. 201:637–648. doi: 10.1148/radiology.201.3.8939209
   PubMed Web of Science ®Google Scholar
• Plant C, Teipel SJ, Oswald A, Bohm C, Meindl T, Mourao-Miranda J, Bokde AW, Hampel H, Ewers M. 2010. Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease. Neuroimage. 50:162–174. doi: 10.1016/j.neuroimage.2009.11.046
   PubMed Web of Science ®Google Scholar
• Poisnel G, Dhilly M, Moustie O, Delamare J, Abbas A, Guilloteau D, Barre L. 2012. PET imaging with [18F]AV-45 in an APP/PS1–21 murine model of amyloid plaque deposition. Neurobiol Aging. 33:2561–2571. doi: 10.1016/j.neurobiolaging.2011.12.024
   PubMed Web of Science ®Google Scholar
• Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, Pokrupa R, Arnold DL. 1996. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med. 2:323–325. doi: 10.1038/nm0396-323
   PubMed Web of Science ®Google Scholar
• Price JL, Davis PB, Morris JC, White DL. 1991. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging. 12:295–312. doi: 10.1016/0197-4580(91)90006-6
   PubMed Web of Science ®Google Scholar
• Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. 1994. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology. 193:637–641. doi: 10.1148/radiology.193.3.7972800
   PubMed Web of Science ®Google Scholar
• Riek R, Guntert P, Dobeli H, Wipf B, Wuthrich K. 2001. NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1–40)(ox) and A beta(1–42)(ox). Eur J Biochem/FEBS. 268:5930–5936. doi: 10.1046/j.0014-2956.2001.02537.x
   PubMedGoogle Scholar
• Roher AE, Chaney MO, Kuo YM, Webster SD, Stine WB, Haverkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, et al. 1996. Morphology and toxicity of Abeta-(1–42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem. 271:20631–20635. doi: 10.1074/jbc.271.34.20631
   PubMed Web of Science ®Google Scholar
• Rosano C, Zuccotti S, Bolognesi M. 2005. The three-dimensional structure of beta2 microglobulin: results from X-ray crystallography. Biochim Biophys Acta. 1753:85–91. doi: 10.1016/j.bbapap.2005.07.010
   PubMed Web of Science ®Google Scholar
• Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, Semple J, Doddrell DM. 2000. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry. 69:528–530. doi: 10.1136/jnnp.69.4.528
   PubMed Web of Science ®Google Scholar
• Rosen BR, Belliveau JW, Chien D. 1989. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q. 5:263–281.
   PubMedGoogle Scholar
• Ross AJ, Sachdev PS, Wen W, Valenzuela MJ, Brodaty H. 2005. Cognitive correlates of 1H MRS measures in the healthy elderly brain. Brain Res Bull. 66:9–16. doi: 10.1016/j.brainresbull.2005.01.015
   PubMed Web of Science ®Google Scholar
• Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Gruetter R. 1997. In-vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem. 68:161–172. doi: 10.1016/S0301-4622(97)00032-X
   PubMed Web of Science ®Google Scholar
• Rousset OG, Ma Y, Evans AC. 1998. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 39:904–911.
   PubMed Web of Science ®Google Scholar
• Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, et al. 2008. Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94–9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 7:129–135. doi: 10.1016/S1474-4422(08)70001-2
   PubMed Web of Science ®Google Scholar
• Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, et al. 2007. Imaging beta-amyloid burden in aging and dementia. Neurology. 68:1718–1725. doi: 10.1212/01.wnl.0000261919.22630.ea
   PubMed Web of Science ®Google Scholar
• Rupsingh R, Borrie M, Smith M, Wells JL, Bartha R. 2011. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol Aging. 32:802–810. doi: 10.1016/j.neurobiolaging.2009.05.002
   PubMed Web of Science ®Google Scholar
• Rusinek H, de Leon MJ, George AE, Stylopoulos LA, Chandra R, Smith G, Rand T, Mourino M, Kowalski H. 1991. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology. 178:109–114. doi: 10.1148/radiology.178.1.1984287
   PubMed Web of Science ®Google Scholar
• Salmon E, Sadzot B, Maquet P, Degueldre C, Lemaire C, Rigo P, Comar D, Franck G. 1994. Differential diagnosis of Alzheimer's disease with PET. J Nucl Med. 35:391–398.
   PubMed Web of Science ®Google Scholar
• Sandson TA, Felician O, Edelman RR, Warach S. 1999. Diffusion-weighted magnetic resonance imaging in Alzheimer's disease. Dement Geriatr Cogn Disord. 10:166–171. doi: 10.1159/000017099
   PubMed Web of Science ®Google Scholar
• Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M, Wiltzius JJ, McFarlane HT, et al. 2007. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature. 447:453–457. doi: 10.1038/nature05695
   PubMed Web of Science ®Google Scholar
• Saykin AJ, Flashman LA, Frutiger SA, Johnson SC, Mamourian AC, Moritz CH, O'Jile JR, Riordan HJ, Santulli RB, Smith CA, et al. 1999. Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation. J Int Neuropsychol Soc. 5:377–392. doi: 10.1017/S135561779955501X
   PubMed Web of Science ®Google Scholar
• Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. 2002. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA. 99:4703–4707.
   Google Scholar
• Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, et al. 1997. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology. 49:1513–1521. doi: 10.1212/WNL.49.6.1513
   PubMed Web of Science ®Google Scholar
• Schulz JB, Dichgans J. 1999. Molecular pathogenesis of movement disorders: are protein aggregates a common link in neuronal degeneration?. Curr Opin Neurol. 12:433–439. doi: 10.1097/00019052-199908000-00010
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 81:741–766.
   PubMed Web of Science ®Google Scholar
• Seneca N, Cai L, Liow JS, Zoghbi SS, Gladding RL, Hong J, Pike VW, Innis RB. 2007. Brain and whole-body imaging in nonhuman primates with [11C]MeS-IMPY, a candidate radioligand for beta-amyloid plaques. Nucl Med Biol. 34:681–689. doi: 10.1016/j.nucmedbio.2007.06.002
   PubMed Web of Science ®Google Scholar
• Shao H, Jao S, Ma K, Zagorski MG. 1999. Solution structures of micelle-bound amyloid beta-(1–40) and beta-(1–42) peptides of Alzheimer's disease. J Mol Biol. 285:755–773. doi: 10.1006/jmbi.1998.2348
   PubMed Web of Science ®Google Scholar
• Shivji AP, Brown F, Davies MC, Jennings KH, Roberts CJ, Tendler S, Wilkinson MJ, Williams PM. 1995. Scanning tunnelling microscopy studies of beta-amyloid fibril structure and assembly. FEBS Lett. 371:25–28. doi: 10.1016/0014-5793(95)00858-7
   PubMed Web of Science ®Google Scholar
• Shoghi-Jadid K, Barrio JR, Kepe V, Wu HM, Small GW, Phelps ME, Huang SC. 2005. Imaging beta-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerization. Nucl Med Biol. 32:337–351. doi: 10.1016/j.nucmedbio.2005.02.003
   PubMed Web of Science ®Google Scholar
• Shonk T, Ross BD. 1995. Role of increased cerebral myo-inositol in the dementia of Down syndrome. Mag Reson Med. 33:858–861. doi: 10.1002/mrm.1910330619
   PubMed Web of Science ®Google Scholar
• Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD. 1995. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology. 195:65–72. doi: 10.1148/radiology.195.1.7892497
   PubMed Web of Science ®Google Scholar
• Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, et al. 2000a. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA. 97:6037–6042.
   Google Scholar
• Small SA, Nava AS, Perera GM, Delapaz R, Stern Y. 2000b. Evaluating the function of hippocampal subregions with high-resolution MRI in Alzheimer's disease and aging. Microsc Res Tech. 51:101–108. doi: 10.1002/1097-0029(20001001)51:1<101::AID-JEMT11>3.0.CO;2-H
   PubMed Web of Science ®Google Scholar
• Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, Avison MJ. 1999. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology. 53:1391–1396. doi: 10.1212/WNL.53.7.1391
   PubMed Web of Science ®Google Scholar
• Smith DG, Cappai R, Barnham KJ. 2007. The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta. 1768:1976–1990. doi: 10.1016/j.bbamem.2007.02.002
   PubMed Web of Science ®Google Scholar
• Smith GS, de Leon MJ, George AE, Kluger A, Volkow ND, McRae T, Golomb J, Ferris SH, Reisberg B, Ciaravino J, et al. 1992. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. Arch Neurol. 49:1142–1150. doi: 10.1001/archneur.1992.00530350056020
   PubMed Web of Science ®Google Scholar
• Stellato F, Menestrina G, Serra MD, Potrich C, Tomazzolli R, Meyer-Klaucke W, Morante S. 2006. Metal binding in amyloid beta-peptides shows intra- and inter-peptide coordination modes. Eur Biophys J. 35:340–351. doi: 10.1007/s00249-005-0041-7
   PubMed Web of Science ®Google Scholar
• Steven A, Belnap D. 2005. Electron microscopy and image processing: an essential tool for structural analysis of macromolecules. Current protocols in protein science / editorial board, John E Coligan [et al]. Dec;Chapter 17:Unit 17 12.
   Google Scholar
• Stokes CE, Hawthorne JN. 1987. Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. J Neurochem. 48:1018–1021. doi: 10.1111/j.1471-4159.1987.tb05619.x
   PubMed Web of Science ®Google Scholar
• Stoub TR, Bulgakova M, Leurgans S, Bennett DA, Fleischman D, Turner DA, de Toledo-Morrell L. 2005. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology. 64:1520–1524. doi: 10.1212/01.WNL.0000160089.43264.1A
   PubMed Web of Science ®Google Scholar
• Streltsov V. 2008. X-ray absorption and diffraction studies of the metal binding sites in amyloid beta-peptide. Eur Biophys J. 37:257–263. doi: 10.1007/s00249-007-0232-5
   PubMed Web of Science ®Google Scholar
• Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CC. 1997. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol. 273:729–739. doi: 10.1006/jmbi.1997.1348
   PubMed Web of Science ®Google Scholar
• Sung YH, Eliezer D. 2006. Secondary structure and dynamics of micelle bound beta- and gamma-synuclein. Protein Sci. 15:1162–1174. doi: 10.1110/ps.051803606
   PubMed Web of Science ®Google Scholar
• Swahn BM, Wensbo D, Sandell J, Sohn D, Slivo C, Pyring D, Malmstrom J, Arzel E, Vallin M, Bergh M, et al. 2010. Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for beta-amyloid plaques. Bioorg Med Chem Lett. 20:1976–1980. doi: 10.1016/j.bmcl.2010.01.105
   PubMed Web of Science ®Google Scholar
• Tabner BJ, Turnbull S, El-Agnaf O, Allsop D. 2001. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr Top Med Chem. 1:507–517. doi: 10.2174/1568026013394822
   PubMedGoogle Scholar
• Talafous J, Marcinowski KJ, Klopman G, Zagorski MG. 1994. Solution structure of residues 1–28 of the amyloid beta-peptide. Biochemistry. 33:7788–7796. doi: 10.1021/bi00191a006
   PubMed Web of Science ®Google Scholar
• Tanabe JL, Amend D, Schuff N, DiSclafani V, Ezekiel F, Norman D, Fein G, Weiner MW. 1997. Tissue segmentation of the brain in Alzheimer disease. AJNR Am J Neuroradiol. 18:115–123.
   PubMed Web of Science ®Google Scholar
• Tanna NK, Kohn MI, Horwich DN, Jolles PR, Zimmerman RA, Alves WM, Alavi A. 1991. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. Radiology. 178:123–130. doi: 10.1148/radiology.178.1.1984290
   PubMed Web of Science ®Google Scholar
• Thulborn KR, Martin C, Voyvodic JT. 2000. Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers. AJNR Am J Neuroradiol. 21:524–531.
   PubMed Web of Science ®Google Scholar
• Tomaselli S, Esposito V, Vangone P, van Nuland NA, Bonvin AM, Guerrini R, Tancredi T, Temussi PA, Picone D. 2006. The alpha-to-beta conformational transition of Alzheimer's Abeta-(1–42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. Chembiochem: A Euro J Chem Biol. 7:257–267. doi: 10.1002/cbic.200500223
   PubMed Web of Science ®Google Scholar
• Torok M, Milton S, Kayed R, Wu P, McIntire T, Glabe CG, Langen R. 2002. Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem. 277:40810–40815. doi: 10.1074/jbc.M205659200
   PubMed Web of Science ®Google Scholar
• Tycko R, Ishii Y. 2003. Constraints on supramolecular structure in amyloid fibrils from two-dimensional solid-state NMR spectroscopy with uniform isotopic labeling. J Am Chem Soc. 125:6606–6607. doi: 10.1021/ja0342042
   PubMed Web of Science ®Google Scholar
• Tycko R. 2004. Progress towards a molecular-level structural understanding of amyloid fibrils. Curr Opin Struct Biol. 14:96–103. doi: 10.1016/j.sbi.2003.12.002
   PubMed Web of Science ®Google Scholar
• Tycko R. 2006a. Characterization of amyloid structures at the molecular level by solid state nuclear magnetic resonance spectroscopy. Methods Enzymol. 413:103–122. doi:10.1016/S0076-6879(06)13006-2
   PubMed Web of Science ®Google Scholar
• Tycko R. 2006b. Molecular structure of amyloid fibrils: insights from solid-state NMR. Q Rev Biophys. 39:1–55. doi: 10.1017/S0033583506004173
   PubMed Web of Science ®Google Scholar
• Tycko R. 2006c. Solid-state NMR as a probe of amyloid structure. Protein Pept Lett. 13:229–234. 10.2174/092986606775338470 doi: 10.2174/092986606775338470
   PubMed Web of Science ®Google Scholar
• Vassar PS, Culling CF. 1959. Fluorescent stains, with special reference to amyloid and connective tissues. Arch Pathol. 68:487–498.
   PubMedGoogle Scholar
• Vemuri P, Gunter JL, Senjem ML, Whitwell JL, Kantarci K, Knopman DS, Boeve BF, Petersen RC, Jack CR, Jr. 2008. Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage. 39:1186–1197. doi: 10.1016/j.neuroimage.2007.09.073
   PubMed Web of Science ®Google Scholar
• Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, O'Keefe G, Ackerman U, Tochon-Danguy H, Chan JG, et al. 2011. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med. 52:1210–1217. doi: 10.2967/jnumed.111.089730
   PubMed Web of Science ®Google Scholar
• Wahlund LO, Andersson-Lundman G, Basun H, Almkvist O, Bjorksten KS, Saaf J, Wetterberg L. 1993. Cognitive functions and brain structures: a quantitative study of CSF volumes on Alzheimer patients and healthy control subjects. Magn Reson Imaging. 11:169–174. doi:10.1016/0730-725X(93)90021-5
   PubMed Web of Science ®Google Scholar
• Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB. 1999. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem. 274:25945–25952. doi: 10.1074/jbc.274.36.25945
   PubMed Web of Science ®Google Scholar
• Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB. 1997. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem. 272:22364–22372. doi: 10.1074/jbc.272.35.22364
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhou C, Wang C, Wan L, Fang X, Bai C. 2003. AFM and STM study of beta-amyloid aggregation on graphite. Ultramicroscopy. 97:73–79. doi: 10.1016/S0304-3991(03)00031-7
   PubMed Web of Science ®Google Scholar
• Ward RV, Jennings KH, Jepras R, Neville W, Owen DE, Hawkins J, Christie G, Davis JB, George A, Karran EH, et al. 2000. Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem J. 348 Pt 1:137–144. doi: 10.1042/0264-6021:3480137
   PubMed Web of Science ®Google Scholar
• Watanabe T, Shiino A, Akiguchi I. 2012. Hippocampal metabolites and memory performances in patients with amnestic mild cognitive impairment and Alzheimer's disease. Neurobiol Learn Mem. 97:289–293. doi: 10.1016/j.nlm.2012.01.006
   PubMed Web of Science ®Google Scholar
• Woo DC, Lee SH, Lee DW, Kim SY, Kim GY, Rhim HS, Choi CB, Kim HY, Lee CU, Choe BY. 2010. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS. Behav Brain Res. 211:125–131. doi: 10.1016/j.bbr.2010.03.026
   PubMed Web of Science ®Google Scholar
• Wood SJ, Maleeff B, Hart T, Wetzel R. 1996. Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. J Mol Biol. 256:870–877. doi: 10.1006/jmbi.1996.0133
   PubMed Web of Science ®Google Scholar
• Wu C, Wang Z, Lei H, Zhang W, Duan Y. 2007. Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations. J Am Chem Soc. 129:1225–1232. doi: 10.1021/ja0662772
   PubMed Web of Science ®Google Scholar
• Yan Y, Wang C. 2006. Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity. J Mol Biol. 364:853–862. doi: 10.1016/j.jmb.2006.09.046
   PubMed Web of Science ®Google Scholar
• Zamrini E, De Santi S, Tolar M. 2004. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease. Neurobiol Aging. 25:685–691. doi: 10.1016/j.neurobiolaging.2004.02.009
   PubMed Web of Science ®Google Scholar
• Zeeb M, Balbach J. 2004. Protein folding studied by real-time NMR spectroscopy. Methods. 34:65–74. doi: 10.1016/j.ymeth.2004.03.014
   PubMed Web of Science ®Google Scholar
• Zhang B, Li M, Sun ZZ, Zhu B, Yuan L, Wang Y, Xu Y. 2009. Evaluation of functional MRI markers in mild cognitive impairment. J Clin Neurosci. 16:635–641. doi: 10.1016/j.jocn.2008.07.080
   PubMed Web of Science ®Google Scholar
• Zhou Y, Resnick SM, Ye W, Fan H, Holt DP, Klunk WE, Mathis CA, Dannals R, Wong DF. 2007. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. Neuroimage. 36:298–312. doi: 10.1016/j.neuroimage.2007.03.004
   PubMed Web of Science ®Google Scholar
• Ziegler SI. 2005. Positron emission tomography: principles, technology, and recent developments. Nucl Phys A. 752:679–687. doi:10.1016/j.nuclphysa.2005.02.067
   Web of Science ®Google Scholar